When ASD is first suspected by parents/caregivers or primary healthcare providers, an initial screening exam is completed that includes both a patient and provider questionnaire along with a physical examination
The medication works by: Enhancing insulin secretion in a glucose-dependent manner, reducing the risk of hypoglycemia Suppressing glucagon release when blood glucose levels are elevated Slowing gastric emptying , which prolongs satiety and reduces appetite Acting on central appetite regulation in the hypothalamus to decrease food intake Zepbound is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and gradually titrated upward (5 mg, 7.5 mg, 10 mg, 12.5 mg, to a maximum of 15 mg) based on individual tolerance and therapeutic response
Neutralization of Oxidative Stress Markers: Studies show that it may reduce elevated levels of the oxidative stress marker malondialdehyde (MDA) and normalize NO tissue values
They are typically administered via subcutaneous injection, though some may be available in oral, nasal, or topical forms